{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:47:42Z","timestamp":1790524062732,"version":"4.1.0"},"reference-count":85,"publisher":"Life Science Alliance, LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001625","name":"Foundation to Eradicate Duchenne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001625","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clark Charitable Foundation"},{"DOI":"10.13039\/501100001266","name":"Action Duchenne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001266","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"name":"NIH","award":["K99HL130035"],"award-info":[{"award-number":["K99HL130035"]}]},{"name":"NIH","award":["R00HL130035"],"award-info":[{"award-number":["R00HL130035"]}]},{"name":"NIH","award":["L40AR068727"],"award-info":[{"award-number":["L40AR068727"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-17-1-047"],"award-info":[{"award-number":["W81XWH-17-1-047"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["T32AR056993"],"award-info":[{"award-number":["T32AR056993"]}]},{"name":"CRI and the Intellectual and Developmental Disabilities Research Center Award","award":["U54HD090257"],"award-info":[{"award-number":["U54HD090257"]}]}],"content-domain":{"domain":["life-science-alliance.org"],"crossmark-restriction":true},"short-container-title":["Life Sci. Alliance"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>Cardiomyopathy is a leading cause of death for Duchenne muscular dystrophy. Here, we find that the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) can share common ligands but play distinct roles in dystrophic heart and skeletal muscle pathophysiology. Comparisons of their ligand structures indicate that the \u03949,11 modification of the first-in-class drug vamorolone enables it to avoid interaction with a conserved receptor residue (N770\/N564), which would otherwise activate transcription factor properties of both receptors. Reporter assays show that vamorolone and eplerenone are MR antagonists, whereas prednisolone is an MR agonist. Macrophages, cardiomyocytes, and CRISPR knockout myoblasts show vamorolone is also a dissociative GR ligand that inhibits inflammation with improved safety over prednisone and GR-specific deflazacort. In mice, hyperaldosteronism activates MR-driven hypertension and kidney phenotypes. We find that genetic dystrophin loss provides a second hit for MR-mediated cardiomyopathy in Duchenne muscular dystrophy model mice, as aldosterone worsens fibrosis, mass and dysfunction phenotypes. Vamorolone successfully prevents MR-activated phenotypes, whereas prednisolone activates negative MR and GR effects. In conclusion, vamorolone targets dual nuclear receptors to treat inflammation and cardiomyopathy with improved safety.<\/jats:p>","DOI":"10.26508\/lsa.201800186","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:25:12Z","timestamp":1549909512000},"page":"e201800186","update-policy":"https:\/\/doi.org\/10.26508\/lsa.crossmarkpolicy","source":"Crossref","is-referenced-by-count":85,"title":["Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy"],"prefix":"10.26508","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-2068","authenticated-orcid":true,"given":"Christopher R","family":"Heier","sequence":"first","affiliation":[{"name":"Department of Genomics and Precision Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA"},{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson A","family":"Fiorillo","sequence":"additional","affiliation":[{"name":"Department of Genomics and Precision Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA"},{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B","family":"Tully","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asya","family":"Tucker","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi A","family":"Mazala","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitipong","family":"Uaesoontrachoon","sequence":"additional","affiliation":[{"name":"AGADA Biosciences Incorporated, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadish","family":"Srinivassane","sequence":"additional","affiliation":[{"name":"AGADA Biosciences Incorporated, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M","family":"Damsker","sequence":"additional","affiliation":[{"name":"ReveraGen BioPharma, Incorporated, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P","family":"Hoffman","sequence":"additional","affiliation":[{"name":"AGADA Biosciences Incorporated, Halifax, Nova Scotia, Canada"},{"name":"ReveraGen BioPharma, Incorporated, Rockville, MD, USA"},{"name":"School of Pharmacy and Pharmaceutical Sciences, Binghamton University\u2014State University of New York (SUNY), Binghamton, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[{"name":"AGADA Biosciences Incorporated, Halifax, Nova Scotia, Canada"},{"name":"ReveraGen BioPharma, Incorporated, Rockville, MD, USA"},{"name":"School of Pharmacy and Pharmaceutical Sciences, Binghamton University\u2014State University of New York (SUNY), Binghamton, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F","family":"Spurney","sequence":"additional","affiliation":[{"name":"Department of Genomics and Precision Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA"},{"name":"Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA"},{"name":"Division of Cardiology, Children's National Heart Institute, Children's National Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12380","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"2019021110250532000_2.1.e201800186.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp028"},{"key":"2019021110250532000_2.1.e201800186.2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001950"},{"key":"2019021110250532000_2.1.e201800186.3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24370"},{"key":"2019021110250532000_2.1.e201800186.4","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-2098"},{"key":"2019021110250532000_2.1.e201800186.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00817-6"},{"key":"2019021110250532000_2.1.e201800186.6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F"},{"key":"2019021110250532000_2.1.e201800186.7","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"2019021110250532000_2.1.e201800186.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-009-0024-y"},{"key":"2019021110250532000_2.1.e201800186.9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00269.2016"},{"key":"2019021110250532000_2.1.e201800186.10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw331"},{"key":"2019021110250532000_2.1.e201800186.11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000173836.09176.c4"},{"key":"2019021110250532000_2.1.e201800186.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.2979"},{"key":"2019021110250532000_2.1.e201800186.13","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-17-0155"},{"key":"2019021110250532000_2.1.e201800186.14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv460"},{"key":"2019021110250532000_2.1.e201800186.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.09.007"},{"key":"2019021110250532000_2.1.e201800186.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-016-0956-8"},{"key":"2019021110250532000_2.1.e201800186.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063871"},{"key":"2019021110250532000_2.1.e201800186.18","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0030fje"},{"key":"2019021110250532000_2.1.e201800186.19","first-page":"650","article-title":"Three new epoxy-spirolactone derivatives: Characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"2019021110250532000_2.1.e201800186.20","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90169-6"},{"key":"2019021110250532000_2.1.e201800186.21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.117531"},{"key":"2019021110250532000_2.1.e201800186.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020970"},{"key":"2019021110250532000_2.1.e201800186.23","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-014-0133-y"},{"key":"2019021110250532000_2.1.e201800186.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(02)00140-2"},{"key":"2019021110250532000_2.1.e201800186.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90742-8"},{"key":"2019021110250532000_2.1.e201800186.26","doi-asserted-by":"publisher","DOI":"10.1007\/s004670000337"},{"key":"2019021110250532000_2.1.e201800186.27","doi-asserted-by":"publisher","DOI":"10.1159\/000068446"},{"key":"2019021110250532000_2.1.e201800186.28","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00134.2017"},{"key":"2019021110250532000_2.1.e201800186.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23819"},{"key":"2019021110250532000_2.1.e201800186.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.983023"},{"key":"2019021110250532000_2.1.e201800186.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.2845584"},{"key":"2019021110250532000_2.1.e201800186.32","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23831"},{"key":"2019021110250532000_2.1.e201800186.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003217"},{"key":"2019021110250532000_2.1.e201800186.34","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510397"},{"key":"2019021110250532000_2.1.e201800186.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2008.04.016"},{"key":"2019021110250532000_2.1.e201800186.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011220"},{"key":"2019021110250532000_2.1.e201800186.37","first-page":"783","article-title":"Immunosuppressive effects of deflazacort: A new glucocorticoid with bone-sparing and carbohydrate-sparing properties: Comparison with prednisone","volume":"8","author":"Hahn","year":"1981","journal-title":"J Rheumatol"},{"key":"2019021110250532000_2.1.e201800186.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(03)00030-8"},{"key":"2019021110250532000_2.1.e201800186.39","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2506"},{"key":"2019021110250532000_2.1.e201800186.40","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302621"},{"key":"2019021110250532000_2.1.e201800186.41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39845"},{"key":"2019021110250532000_2.1.e201800186.42","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.13.10.6231"},{"key":"2019021110250532000_2.1.e201800186.43","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90579-4"},{"key":"2019021110250532000_2.1.e201800186.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2018.02.010"},{"key":"2019021110250532000_2.1.e201800186.45","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-107"},{"key":"2019021110250532000_2.1.e201800186.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"2019021110250532000_2.1.e201800186.47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2049"},{"key":"2019021110250532000_2.1.e201800186.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088360"},{"key":"2019021110250532000_2.1.e201800186.49","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90504-6"},{"key":"2019021110250532000_2.1.e201800186.50","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.10.5.2327"},{"key":"2019021110250532000_2.1.e201800186.51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M000228200"},{"key":"2019021110250532000_2.1.e201800186.52","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.163287"},{"key":"2019021110250532000_2.1.e201800186.53","doi-asserted-by":"publisher","DOI":"10.3233\/JND-160173"},{"key":"2019021110250532000_2.1.e201800186.54","doi-asserted-by":"publisher","DOI":"10.1016\/0960-8966(91)90099-E"},{"key":"2019021110250532000_2.1.e201800186.55","doi-asserted-by":"publisher","DOI":"10.1038\/323646a0"},{"key":"2019021110250532000_2.1.e201800186.56","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(90)90082-G"},{"key":"2019021110250532000_2.1.e201800186.57","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01135.2008"},{"key":"2019021110250532000_2.1.e201800186.58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05910-1"},{"key":"2019021110250532000_2.1.e201800186.59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"2019021110250532000_2.1.e201800186.60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"2019021110250532000_2.1.e201800186.61","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.031716"},{"key":"2019021110250532000_2.1.e201800186.62","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.6.1306"},{"key":"2019021110250532000_2.1.e201800186.63","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70318-7"},{"key":"2019021110250532000_2.1.e201800186.64","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0590-8"},{"key":"2019021110250532000_2.1.e201800186.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.12.014"},{"key":"2019021110250532000_2.1.e201800186.66","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01803"},{"key":"2019021110250532000_2.1.e201800186.67","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.131110"},{"key":"2019021110250532000_2.1.e201800186.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2006.07.007"},{"key":"2019021110250532000_2.1.e201800186.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.049"},{"key":"2019021110250532000_2.1.e201800186.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.06.028"},{"key":"2019021110250532000_2.1.e201800186.71","unstructured":"Sanders B , Cummings EE (2017) Letter to Jeffrey S. Aronin, Chairman and Chief Executive Officer, Marathon Pharmaceuticals, LLC. Congress of the United States (https:\/\/www.sanders.senate.gov\/download\/february-2017-letter-to-marathon?id=06256FA4-D5AA-4E3F-AD40-589E7D664E84&download=1&inline=file)"},{"key":"2019021110250532000_2.1.e201800186.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)03429-X"},{"key":"2019021110250532000_2.1.e201800186.73","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(62)90668-2"},{"key":"2019021110250532000_2.1.e201800186.74","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21211"},{"key":"2019021110250532000_2.1.e201800186.75","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-11-20"},{"key":"2019021110250532000_2.1.e201800186.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.07.021"},{"key":"2019021110250532000_2.1.e201800186.77","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64454-9"},{"key":"2019021110250532000_2.1.e201800186.78","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300144"},{"key":"2019021110250532000_2.1.e201800186.79","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu033"},{"key":"2019021110250532000_2.1.e201800186.80","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.4049\/jimmunol.153.5.2052","article-title":"NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene","volume":"153","author":"Ueda","year":"1994","journal-title":"J Immunol"},{"key":"2019021110250532000_2.1.e201800186.81","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011401825680"},{"key":"2019021110250532000_2.1.e201800186.82","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5b00010"},{"key":"2019021110250532000_2.1.e201800186.83","doi-asserted-by":"publisher","DOI":"10.1038\/nature03844"},{"key":"2019021110250532000_2.1.e201800186.84","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0471"},{"key":"2019021110250532000_2.1.e201800186.85","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009492"}],"container-title":["Life Science Alliance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.26508\/lsa.201800186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T14:06:00Z","timestamp":1704895560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.life-science-alliance.org\/lookup\/doi\/10.26508\/lsa.201800186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2,11]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.26508\/lsa.201800186"],"URL":"https:\/\/doi.org\/10.26508\/lsa.201800186","relation":{},"ISSN":["2575-1077"],"issn-type":[{"value":"2575-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}